SAS-based discrete event simulation (DES) solution to evaluate pediatric oncology phase I trial designs.

被引:0
|
作者
Jayaraman, Bhuvana [1 ]
Skolnik, Jeffrey M. [1 ]
Patel, Dimple [1 ]
Barrett, Jeffrey S. [1 ]
机构
[1] Childrens Hosp Philadelphia, Div Clin Pharmacol, Philadelphia, PA 19104 USA
来源
JOURNAL OF CLINICAL PHARMACOLOGY | 2007年 / 47卷 / 09期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
87
引用
收藏
页码:1202 / 1202
页数:1
相关论文
共 6 条
  • [1] A SAS-based solution to evaluate study design efficiency of phase I pediatric oncology trials via discrete event simulation
    Barrett, Jeffrey S.
    Jayaraman, Bhuvana
    Patel, Dimple
    Skolnik, Jeffrey M.
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2008, 90 (03) : 240 - 250
  • [2] Discrete Event Simulation Applied to Pediatric Phase I Oncology Designs
    Barrett, J. S.
    Skolnik, J. M.
    Jayaraman, B.
    Patel, D.
    Adamson, P. C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (06) : 729 - 733
  • [3] Optimal phase I dose-escalation trial designs in oncology-A simulation study
    Gerke, Oke
    Siedentop, Harald
    STATISTICS IN MEDICINE, 2008, 27 (26) : 5329 - 5344
  • [4] Evaluation of phase I clinical trial designs for combinational agents along with guidance based on simulation studies
    Wang, Shu
    Sayour, Elias
    Lee, Ji-Hyun
    JOURNAL OF APPLIED STATISTICS, 2023, 50 (09) : 2055 - 2078
  • [5] An exploratory study on the use of game-based learning using Microsoft Kinect to teach oncology phase I clinical trial designs
    Bilsland, Alan
    Kelly, Caroline
    Roccisana, Jennifer
    Paul, James
    Jones, Rob
    Edwards, Joanne
    Roseweir, Antonia
    Stein, Torsten
    West, Katherine
    BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 9 - 9
  • [6] A simulation-based comparison of the traditional method, Rolling-6 design and a frequentist version of the continual reassessment method with special attention to trial duration in pediatric Phase I oncology trials
    Onar-Thomas, Arzu
    Xiong, Zang
    CONTEMPORARY CLINICAL TRIALS, 2010, 31 (03) : 259 - 270